Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I; PSG PRECEPT Investigators; Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, Lang A, Fahn S, Gauger L, Goetz C.
Schwid SR, et al.
Mov Disord. 2010 Sep 15;25(12):1801-8. doi: 10.1002/mds.23006.
Mov Disord. 2010.
PMID: 20669311
Clinical Trial.